Latest Study on “Hemodialysis And Peritoneal Dialysis Market Size, Share, Trends, Growth, Production, Consumption, Revenue, Company Analysis and Forecast 2021-2027”.
The global Hemodialysis And Peritoneal Dialysis market size is expected to be worth around US$ 120.1 Billion by 2027, according to a new report by nova one advisor.
The global Hemodialysis And Peritoneal Dialysis market size was valued at US$ 75.9 Billion in 2020 and is anticipated to grow at a CAGR of 7.2% during forecast period 2021 to 2027.
Overview of Hemodialysis And Peritoneal Dialysis Market Study
Hemodialysis And Peritoneal Dialysis market study conducted by Nova One Advisor is intended at helping stakeholders get a comprehensive overview of potential challenges and undiscovered opportunities. The report offers exclusive insights to help companies and their customers to make informed decision to sustain growth through the assessment period.
Get your Customized Research Report@ https://www.novaoneadvisor.com/report/customization/5784
Growth in this market is driven by the increasing number of ESRD patients, growing prevalence of diabetes & hypertension, shortage of organ donors and risks associated with transplants, technological advancements, and initiatives by leading players to introduce advanced products & services in the market. However, the risks & complications associated with dialysis and product recall is likely to restrain the growth of this market to a certain extent.
Hemodialysis and Peritoneal Dialysis Market Dynamics
Driver: Increase in the prevalence of incidence of End-Stage Renal Disease(ESRD)
The growing worldwide incidence of ESRD is, therefore, expected to increase the demand for dialysis treatment. Globally, around 2 million people are affected by ESRD each year (Source: USRDS Annual Data Report, 2018). The progression of renal diseases worldwide is anticipated to boost the demand for dialysis to maintain proper kidney functioning. With the rapid growth in the geriatric population globally, the prevalence of kidney-related diseases is expected to increase significantly. This, in turn, is expected to propel the growth of the hemodialysis and peritoneal dialysis market at a significant rate during the forecast period.
Restraint: Risks and complications associated with the dialysis
Complications such as cardiac diseases (arrhythmic mechanisms or sudden cardiac arrest) and vascular access-related complications such as bleeding & infection, low blood pressure, nausea, hernia, hepatitis (B & C), and anemia are the major causes of mortality among dialysis patients. Peritonitis is a common complication of peritoneal dialysis resulting due to the contamination of peritoneal dialysate or tubing with pathogenic skin bacteria or due to catheter-related infections. Peritonitis contributes to the death of ~16% of patients on PD each year in North America (Source: Fresenius Medical Care). This limits the uptake of dialysis procedures.
Opportunity: Emerging markets in APAC and RoW
Emerging markets such as China, India, Brazil, and Mexico are expected to offer significant growth opportunities for players in the hemodialysis and peritoneal dialysis market. Taiwan and Malaysia have the highest incidence of treated ESRD in the 45–65 age group and the ≥75 years age group, as per the US Renal Data System (2020 annual report).
To leverage the significant growth opportunities in emerging countries, players are increasingly focusing on undertaking strategic developments agreements/partnerships with regional/domestic players, geographical expansions, and acquisitions.to increase their presence in these markets and tap a large number of customers. In addition, government funding for the treatment of ESRD, the evolution of home/nocturnal dialysis, and the growing number of dialysis centers are also fuelling the growth of dialysis procedures in emerging countries.
Challenge: Sustainability of small and medium-sized companies in a highly competitive market
The dialysis market is highly diversified and competitive, with a large number of players. Players in this market include tier-I firms, mid-tier firms, and start-up firms. Companies are striving to gain market visibility in this highly competitive market. Also, due to the high capital involved in manufacturing and marketing products and the cumbersome regulatory approval procedure, many companies (especially start-ups and small companies) struggle to survive and keep pace with the growth of the industry. This can create a huge barrier for a particular company to build a long-lasting innovation capability in all market segments.
By HD products and services, the HD services segment is to capture the largest market share of hemodialysis market during the forecast period
The largest market share of this segment is attributed to factors such growing demand for dialysis, increase the number of dialysis services providers, presence of well-established HD services providers in the market, and the strategies adopted by the HD providers in capturing large customer bases through expansion of their services across the globe.
Peritoneal dialysis concentrates/ dialysates to account for the highest share of Peritoneal dialysis market, by products during the forecast period.
The highest share of the PD concentrates/ dialysates segment can be attributed to the rise in number of PD treatment procedures and increased focus of players on boosting the manufacturing capabilities with an aim to introduce advanced PD products.
In-center dialysis segment accounted for the largest share of the hemodialysis and peritoneal dialysis market, by usage, in 2021
The increasing demand for dialysis product among chronic kidney patients, increase focus of players in establishing independent dialysis centers, and growing preference of patients to opt for treatment in in-center dialysis are some of the factors likely to boost the growth of the segment.
ESRD segment accounted for the largest share of the hemodialysis and peritoneal dialysis market, by disease indication, in 2021
The increasing demand for invisible braces among adults due to large adult population base with AKI, increase in prevalence of ESRD, growing awareness about the benefits associated with home peritoneal dialysis, and the growing adoption of dialysis products among ESRD patients.
Buy Complete Assessment of Hemodialysis And Peritoneal Dialysis market Now@ https://www.novaoneadvisor.com/report/checkout/5784
COVID-19 Impact on Hemodialysis And Peritoneal Dialysis Sales
Businesses today are operating in a dynamic environment. Earlier focus primarily concentrated on keeping pace with changing consumer preferences. COVID-19 outbreak was unprecedented and exposed vulnerabilities of various industries. Pandemic-induces obstacles also were registered in the Hemodialysis And Peritoneal Dialysis market.
Sales plummeted as COVID-19 gradually tightened its noose worldwide. Supply-chain disruptions caused massive losses, while demand took nose-dive as consumers remained indoors with affected countries implementing either partial or complete lockdown.
Gradual recovery however is on the cards with the roll out of vaccinations. Nonetheless, consecutive waves of the virus compelled businesses to stay prepared for the worst. As government and healthcare organizations successfully implement steps to contain the spread of COVID-19, industries have begun operations, albeit at a slow and more cautious pace.
Against this backdrop, Nova one advisor’s study predicts gradual recovery for the Hemodialysis And Peritoneal Dialysis market 2021 onwards. This trend will however continue through the course of the report’s assessment period
This report provides detailed company profiles of the key market players. This research report also highlights the competitive landscape of the Hemodialysis And Peritoneal Dialysis market and ranks noticeable companies as per their occurrence in diverse regions across globe and crucial developments initiated by them in the market space. This research study also tracks and evaluates competitive developments, such as collaborations, partnerships, and agreements, mergers and acquisitions; novel product introductions and developments, promotion strategies and Research and Development (R&D) activities in the marketplace. The competitive profiling of these players includes business and financial overview, gross margin, production, sales, and recent developments which can aid in assessing competition in the market.
Some of the prominent players in the Hemodialysis And Peritoneal Dialysis market include:
Baxter; B. Braun Melsungen AG; Nipro Medical Corporation; DaVita Healthcare Partners, Inc.; NxStage Medical Inc; Fresenius Medical Care AG & Co. KGaA
Unravelling the Critical Segments
This research report offers market revenue, sales volume, production assessment and prognoses by classifying it on the basis of various aspects including product type, application/end-user, and region. Further, this research study investigates market size, production, consumption and its development trends at global, regional, and country level for period 2017 to 2027 and covers subsequent region in its scope:
- Conventional hemodialysis
- Short daily hemodialysis
- Nocturnal hemodialysis
- Peritoneal dialysis
- Continuous Ambulatory Peritoneal Dialysis (CAPD)
- Automated Peritoneal Dialysis (APD)
- Water treatment system
- United Kingdom
- Rest of Europe
- Southeast Asia
- Rest of Asia Pacific
- Rest of Latin America
Middle East & Africa (MEA)
- North Africa
- South Africa
- Rest of Middle East & Africa
Browse Complete Table of Content@ https://www.novaoneadvisor.com/toc/hemodialysis-and-peritoneal-dialysis-market
Why Buy this Report?
The purpose of Nova one advisor’s Hemodialysis And Peritoneal Dialysis market study is to provide stakeholders with a detailed picture of potential barriers and untapped opportunities. The report contains exclusive information to assist businesses in making informed decisions about how to maintain growth throughout the assessment period.
Download This Full Research Report, Click Here@ https://www.novaoneadvisor.com/report/checkout/5784
Nova One Advisor is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Nova One Advisor has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semi-conductors, chemicals, automotive, and aerospace & defense, among different ventures present globally.
Call: +1 9197 992 333